Tag: Featured Startup

Problem We’re Solving Traumatic non-compressible hemorrhage is the number 1 cause of death for Americans between the ages 1 and 44, in battlefield conditions as well as civilian scenarios. Each year, 160+k individuals die from traumatic injury, of which it is estimated that up to 35% (55+K) are preventable with more adequate, pre-hospital hemorrhage control.… Continue reading Haima

Problem We’re Solving Medication mismanagement causes a huge amount of morbidity and mortality and is a major cause of hospitalizations – interactions, allergies, polypharmacy, missed refills, poor adherence etc. However, these all occur when the patient in not in the clinic – finding ways to scalably engage these patients that are in the community triage… Continue reading ScalaMed

Problem We’re Solving Despite the use of targeted therapies, one in three cancer patients still dies within 5 years from diagnosis. Wealthy patients can afford the implantation of their tumor samples in mice for personalized drug testing to identify the best drugs for their tumors. The problem is the time it takes. If a mouse… Continue reading Lena Bioscience

Problem We’re Solving Cancer continues to inflict devastating consequences worldwide. Initially Bexion was founded to develop innovative treatments for cancer. Bexion is currently running a Phase 2 clinical trial for a rare pediatric brain tumor (Diffuse Intrinsic Pontine Glioma-DIPG) and plans to initiate two additional adult Phase 2 programs in 2021. A Phase I, all-comers… Continue reading Bexion

Problem We’re Solving Problem: Every year over 15M in the US and 75M Worldwide have root canals filled with rubber rods (gutta percha) resulting in dead teeth. Prone to infection, bone resorption and brittleness; these tombstones often require several revisions/ tooth. The Holy Grail of Regenerative Endodontic Therapy (RET) is to develop a material that… Continue reading NangioTx